Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
about
Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysisAdvances in the prevention, management, and treatment of community-acquired pneumoniaCommunity acquired pneumonia incidence before and after proton pump inhibitor prescription: population based studyThe best of respiratory infections from the 2015 European Respiratory Society International CongressPre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) diseaseStatin treatment and mortality in bacterial infections--a systematic review and meta-analysisPharmacotherapy and the risk for community-acquired pneumonia.Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study.Mechanisms of neutrophil accumulation in the lungs against bacteria.Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trialsRisk of fracture and pneumonia from acid suppressive drugs.Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.Factors associated with the initiation of proton pump inhibitors in corticosteroid users.Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis.Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?Risk of pneumonia in patients taking statins: population-based nested case-control study.Temporal and within practice variability in the health improvement networkPotential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults.The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.Emerging roles for cholesterol and lipoproteins in lung disease.The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study.The effect of statin therapy on the incidence of infections: a retrospective cohort analysis.Modifiable risk factors for pneumonia requiring hospitalization of community-dwelling older adults: the Health, Aging, and Body Composition Study.Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.Pneumonia risk and use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.Risk factors for community-acquired pneumonia in adults in Europe: a literature review.Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis.Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies.The risks of PPI therapy.Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.The Use of Statins and Risk of Community-Acquired Pneumonia.Pharmacogenomic testing: the case for CYP2C19 proton pump inhibitor gene-drug pairs.Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.
P2860
Q22241389-E8BAE075-AFDA-4C37-81FD-029C6A5B9246Q26753138-AF3BF8D0-13BB-4902-AE0E-45647EFD55E5Q28595726-33FC71DE-DC68-4251-8F8E-2D78D7B0D696Q28598393-AFF44548-DCCF-4252-A0E4-764C9F752A77Q30402302-B30EC395-21E1-4AEF-96E0-E8873089C0CDQ33587600-C20559EF-0623-46DE-B80F-C7C625675B7EQ33626068-036EED88-5BE1-4D97-BB22-E7505501AEFAQ33646565-35B47A48-6105-42AF-9AC0-4BBA98E0DD90Q34026316-CFD0AF95-3E3E-4399-8A0C-3F41BA6981B0Q34086279-8D042DC1-236F-463E-AE0E-B09106DD5660Q34092977-04E721AD-CFFD-4B9F-A544-8203633B902DQ34124510-270EBF13-C10C-4E56-B26B-2B7B1014475AQ34141425-98A590B0-BD1C-4DDA-8140-A192A10FDE9EQ34411415-7CDE7A41-03F5-4C32-B3F3-F2E01F3CB90AQ34479280-B900D7F7-4E24-4B2A-BFCD-C1231EC86D3BQ34562123-E83E5D27-ACBF-4012-A30E-9602A0FE1F88Q35072261-E134FF0D-A33C-4BED-A6BC-8973909CBA5DQ35511988-BFC179B0-A0A0-43C1-9429-3B597526345FQ35578285-A181CF68-36C1-45DB-9D9B-D52C2F76D101Q35887032-1CB222D0-CAE3-4E2A-A5FE-5DA044DCA8DEQ35894584-B1AA94EA-E4DE-44D4-BAE7-C7A5AB7B0339Q36101677-786809C4-D0A1-4C5F-831C-42C323F27E34Q36303634-16D58F1A-2A15-4364-9FF5-4A7EB5F3C488Q36633863-E5ADDD85-0036-46AD-AB79-23378B15971FQ36876210-DF5254E8-EA38-49EF-8767-164977FB925BQ37022226-84D7829A-9263-4977-98C8-3087DE4CA42EQ37088975-BBC2CA42-4426-4140-9462-6648CEFD9A5FQ37178285-2888FE0A-F210-42A4-98E7-D385C60898A1Q37267627-F8C184F0-9539-4F10-B34D-B33F96327EDDQ37658639-25BD0D19-A1B2-49BB-A3FC-3F427B9A8B2CQ37956128-92006B5E-D625-41A1-A783-04D335F9C010Q37983706-5472620E-82D9-454E-B2D8-D668FDC9AAB3Q38018680-3509CF6C-BC61-4FA9-A9E9-698DD593BE00Q38285835-AE02D2CF-00CE-4209-85BF-61C8195C048CQ38419112-2D4A408B-4CBF-4347-86A2-4EF9E1ADD4B6Q39389913-0AE04B77-36C0-487F-B514-9BBEFB9A7029Q41706384-D8BE5BC9-99EB-41EB-838F-97E326702F8BQ55646010-D8165224-1D34-4490-86C4-EF69C608D8A1
P2860
Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Risk of community-acquired pne ...... tion-based case-control study.
@en
Risk of community-acquired pne ...... tion-based case-control study.
@nl
type
label
Risk of community-acquired pne ...... tion-based case-control study.
@en
Risk of community-acquired pne ...... tion-based case-control study.
@nl
prefLabel
Risk of community-acquired pne ...... tion-based case-control study.
@en
Risk of community-acquired pne ...... tion-based case-control study.
@nl
P2093
P2860
P50
P356
P1476
Risk of community-acquired pne ...... tion-based case-control study.
@en
P2093
Christopher J P Smith
Richard B Hubbard
Zara Pogson
P2860
P304
P356
10.1002/PDS.1715
P577
2009-04-01T00:00:00Z